Company intelligence / Profile preview
MelliCell Inc.
Newton, MA, United Statesmellicell.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Preclinical
01
Overview
MelliCell has developed a proprietary platform to generate mature human fat tissue at scale, enabling new approaches to target chronic diseases like diabetes and obesity. The company’s technology allows for the modeling of weight gain in human fat cells, identification of novel therapeutic targets, and development of drugs that address adipocyte dysfunction. Recent NIH/NIDDK SEED Fund support is accelerating their preclinical research with Mass General Brigham/Harvard collaborators. No clinical results reported yet; programs are preclinical/early-stage R&D[1][2][3][4].
- Therapeutic areas
- Metabolic DisordersEndocrinology
- Modalities
- Cell-based therapiesBiologics (adipokines)Drug discovery platforms using engineered adipocytes[1][4][5]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Mass General Brigham/Brigham & Women’s Hospital (collaborative R&D on genetic mutations affecting adipocytes)[1][2]NIH/NIDDK SEED Fund support via Small Business Innovation Research Program[1]
Beyond the preview
Go deeper on MelliCell Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MelliCell Inc..